This inventor holds 1 USPTO granted patent. Top assignees: Sanofi-A Ventis Deutschland Gmbh, University of Ulster. Active years: 2016.
Company Filing History:


Years Active: 2016
Title: Andrees Boehme: Innovator in Neurodegenerative Disease Treatment
Introduction
Andrees Boehme is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His innovative work has led to the development of a unique pharmaceutical composition aimed at improving patient outcomes.
Latest Patents
Andrees Boehme holds a patent for a pharmaceutical composition designed for the prevention and treatment of neurodegenerative diseases. The composition includes desProExendin-4(1-39)-Lys-NHor and a pharmaceutically acceptable salt, along with optional carriers or adjuvants. This patent highlights his commitment to advancing medical science and addressing critical health challenges.
Career Highlights
Throughout his career, Andrees has worked with prominent organizations, including Sanofi-Aventis Deutschland GmbH and the University of Ulster. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Andrees Boehme has collaborated with notable colleagues such as Sibylle Hess and Christian Hoelscher. These partnerships have further enriched his research and development efforts in the pharmaceutical industry.
Conclusion
Andrees Boehme's contributions to the treatment of neurodegenerative diseases through his innovative pharmaceutical compositions demonstrate his dedication to improving healthcare. His work continues to inspire advancements in medical research and patient care.